NGM BIOPHARMACEUTICALS INC (22) | Business Finance (6)
Browse by Subcategory
Recent Contracts
-
Underwriting Agreement, dated as of January 5, 2021, by and among NGM Biopharmaceuticals, Inc., Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and Cowen and Company, LLC
(Filed With SEC on January 6, 2021)
-
Description of Capital Stock
(Filed With SEC on March 17, 2020)
-
Form of Common Stock Certificate
(Filed With SEC on April 1, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on March 25, 2019)
-
Form of Common Stock Certificate
(Filed With SEC on March 25, 2019)
-
2019 Employee Stock Purchase Plan, to be in effect upon completion of this offering
(Filed With SEC on March 25, 2019)